Verrica Pharmaceuticals Inc. (VRCA) stock
VRCANasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.14−0.06 (-1.88%)
Close on Nov 17, 2026Market cap $53.94MP/E –Yield –
Verrica Pharmaceuticals operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Verrica Pharmaceuticals's operating cash flow for the twelve months ending Jun 30, 2026 was -$13.35M. For fiscal 2025 it was -$17.63M. The highest annual figure on record is -$4.58M in fiscal 2017.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$17.63M | – |
| FY2024 | Dec 31, 2024 | -$60.93M | – |
| FY2023 | Dec 31, 2023 | -$38.58M | – |
| FY2022 | Dec 31, 2022 | -$18.65M | – |
| FY2021 | Dec 31, 2021 | -$27.58M | – |
| FY2020 | Dec 31, 2020 | -$30.21M | – |
| FY2019 | Dec 31, 2019 | -$27.41M | – |
| FY2018 | Dec 31, 2018 | -$17.87M | – |
| FY2017 | Dec 31, 2017 | -$4.58M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$9.28M | – |
| Q1 FY2026 | Mar 31, 2026 | -$9.16M | – |
| Q4 FY2025 | Dec 31, 2025 | -$4.59M | – |
| Q3 FY2025 | Sep 30, 2025 | $9.69M | – |
| Q2 FY2025 | Jun 30, 2025 | -$10.04M | – |
| Q1 FY2025 | Mar 31, 2025 | -$12.68M | – |
| Q4 FY2024 | Dec 31, 2024 | -$16.06M | – |
| Q3 FY2024 | Sep 30, 2024 | -$8.56M | – |
| Q2 FY2024 | Jun 30, 2024 | -$16.36M | – |
| Q1 FY2024 | Mar 31, 2024 | -$19.95M | – |
| Q4 FY2023 | Dec 31, 2023 | -$14.51M | – |
| Q3 FY2023 | Sep 30, 2023 | -$14.81M | -911.6% |
| Q2 FY2023 | Jun 30, 2023 | -$4.67M | – |
| Q1 FY2023 | Mar 31, 2023 | -$4.59M | – |
| Q4 FY2022 | Dec 31, 2022 | -$4.95M | – |
| Q3 FY2022 | Sep 30, 2022 | $1.83M | – |
| Q2 FY2022 | Jun 30, 2022 | -$7.18M | -387.4% |
| Q1 FY2022 | Mar 31, 2022 | -$8.34M | – |
| Q4 FY2021 | Dec 31, 2021 | -$8.70M | – |
| Q3 FY2021 | Sep 30, 2021 | -$10.60M | – |
| Q2 FY2021 | Jun 30, 2021 | $2.50M | – |
| Q1 FY2021 | Mar 31, 2021 | -$10.79M | – |
| Q4 FY2020 | Dec 31, 2020 | -$6.10M | – |
| Q3 FY2020 | Sep 30, 2020 | -$7.61M | – |
| Q2 FY2020 | Jun 30, 2020 | -$8.59M | – |
| Q1 FY2020 | Mar 31, 2020 | -$7.91M | – |
| Q4 FY2019 | Dec 31, 2019 | -$8.21M | – |
| Q3 FY2019 | Sep 30, 2019 | -$7.23M | – |
| Q2 FY2019 | Jun 30, 2019 | -$5.05M | – |
| Q1 FY2019 | Mar 31, 2019 | -$6.92M | – |
| Q4 FY2018 | Dec 31, 2018 | -$6.90M | – |
| Q3 FY2018 | Sep 30, 2018 | -$5.14M | – |
| Q2 FY2018 | Jun 30, 2018 | -$3.68M | – |
| Q1 FY2018 | Mar 31, 2018 | -$2.15M | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.85M | – |
| Q3 FY2017 | Sep 30, 2017 | -$1.08M | – |
See a number that looks wrong?